The Children’s Rare Disease Collaborative (CRDC), established in 2018, is a Boston Children’s Hospital-wide initiative that involves over 100 physician-scientists as well as patient families. The atypical diabetes cohort study aims to understand the genetic causes of atypical diabetes, improve diagnostic approaches, and explore targeted treatments.